- Home
- PTCT vs GGB Comparison
PTCT vs GGB Comparison
Compare PTCT & GGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTCT
- GGB
- Stock Information
- Founded
- PTCT 1998
- GGB 1901
- Country
- PTCT United States
- GGB Brazil
- Employees
- PTCT N/A
- GGB N/A
- Industry
- PTCT Biotechnology: Pharmaceutical Preparations
- GGB Steel/Iron Ore
- Sector
- PTCT Health Care
- GGB Industrials
- Exchange
- PTCT Nasdaq
- GGB Nasdaq
- Market Cap
- PTCT 4.8B
- GGB 5.7B
- IPO Year
- PTCT 2013
- GGB 1999
- Fundamental
- Price
- PTCT $63.43
- GGB $3.22
- Analyst Decision
- PTCT Buy
- GGB Strong Buy
- Analyst Count
- PTCT 14
- GGB 1
- Target Price
- PTCT $67.00
- GGB $3.80
- AVG Volume (30 Days)
- PTCT 1.3M
- GGB 17.8M
- Earning Date
- PTCT 11-06-2025
- GGB 10-30-2025
- Dividend Yield
- PTCT N/A
- GGB 3.13%
- EPS Growth
- PTCT N/A
- GGB N/A
- EPS
- PTCT 7.72
- GGB 0.29
- Revenue
- PTCT $1,764,929,000.00
- GGB $12,681,996,398.00
- Revenue This Year
- PTCT $119.89
- GGB $6.34
- Revenue Next Year
- PTCT N/A
- GGB $4.87
- P/E Ratio
- PTCT $8.28
- GGB $10.54
- Revenue Growth
- PTCT 96.00
- GGB 6.96
- 52 Week Low
- PTCT $34.57
- GGB $2.27
- 52 Week High
- PTCT $67.40
- GGB $3.62
- Technical
- Relative Strength Index (RSI)
- PTCT 66.29
- GGB 57.80
- Support Level
- PTCT $57.74
- GGB $3.05
- Resistance Level
- PTCT $67.40
- GGB $3.22
- Average True Range (ATR)
- PTCT 2.31
- GGB 0.07
- MACD
- PTCT 0.16
- GGB 0.00
- Stochastic Oscillator
- PTCT 62.32
- GGB 66.19
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.
About GGB Gerdau S.A.
Gerdau SA produces steel and steel products. The company operates in civil construction, agriculture, automotive, iron ore, exports, research and development, and home steel products sectors. It offers products such as nails, rebar, columns, billets, slabs, tribar tutors, mechanical construction bars, and reinforced steel locks. The company's geographical segment includes Brazil Operations; North America Operations; South America Operations as well as Special Steel Operations. It derives the majority of its revenue from the Brazil Operations segment.